Which of the following is an example of an 'other' error that can cause treatment delays, higher costs, or hospital-acquired infection?

Prepare for the Clinical Chemistry Automation Test with a comprehensive practice quiz. Study with detailed explanations and multiple choice questions to enhance your understanding and boost your confidence. Ace your exam with our prepared material!

Multiple Choice

Which of the following is an example of an 'other' error that can cause treatment delays, higher costs, or hospital-acquired infection?

The main idea is that labeling problems with specimens fall into an “other” category of errors because they sit outside the standard analytical or timing issues and disrupt the entire workflow. When a sample is mislabeled, the link between the patient, the specimen, and the test results is broken. This can trigger delays while the correct patient and sample are re-identified, re-collection or re-routing of tests, and reconciliation of records. Those steps waste time, drive up costs due to repeat testing and additional handling, and can even lead to inappropriate treatment or monitoring—and in the hospital setting, that can increase exposure risk or lead to invasive steps that heighten infection risk. TAT delays in reporting and wrong test ordered are real problems, but they come from different parts of the process (post-analytical timing and test-selection errors, respectively). An incorrect patient ID is a serious form of labeling/identification error as well, but mislabeled samples broadly capture the root cause of misidentification and traceability failures that cascade into delays and extra costs. That's why mislabelled samples are the best example of an “other” error.

The main idea is that labeling problems with specimens fall into an “other” category of errors because they sit outside the standard analytical or timing issues and disrupt the entire workflow. When a sample is mislabeled, the link between the patient, the specimen, and the test results is broken. This can trigger delays while the correct patient and sample are re-identified, re-collection or re-routing of tests, and reconciliation of records. Those steps waste time, drive up costs due to repeat testing and additional handling, and can even lead to inappropriate treatment or monitoring—and in the hospital setting, that can increase exposure risk or lead to invasive steps that heighten infection risk.

TAT delays in reporting and wrong test ordered are real problems, but they come from different parts of the process (post-analytical timing and test-selection errors, respectively). An incorrect patient ID is a serious form of labeling/identification error as well, but mislabeled samples broadly capture the root cause of misidentification and traceability failures that cascade into delays and extra costs. That's why mislabelled samples are the best example of an “other” error.

More practice questions